Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07342608 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum

Study acronym: STARLIGHT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 4 more changesShow less
    • Trial sites expanded: 0 → 14 locations
    • Start date changed from estimate of Mar 31, 2026 to Jun 23, 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 4 of 9 entries
  2. Interventions: Use of LINEA cardiac pacing lead and FLEXIGO delivery catheter (Device) to Use of LINEA cardiac pacing lead (Device)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the clinical investigation is to evaluate the safety and performances of the new LINEA cardiac pacing lead, intended for placement at the interventricular septum.
Trial Details
NCT Number NCT07342608
Lead Sponsor MicroPort CRM
Conditions
(from sponsor)		 Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing
Related terms Bradycardia
Enrollment 450 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov